Skip to main content

Table 3 The results of univariate analysis for renal prognosis

From: Association between hemoglobin and chronic kidney disease progression: a secondary analysis of a prospective cohort study in Japanese patients

Variable

Statistics

Effect size HR(95%CI)

P value

Age(years)

67.352 ± 13.558

0.992 (0.983, 1.001)

0.07672

Gender

 Male

670 (69.647%)

1.0

 

 Female

292 (30.353%)

1.064 (0.816, 1.385)

0.64813

Etiology of CKD

 Diabetic nephropathy,

244 (25.364%)

1.0

 

 Nephrosclerosis,

385 (40.021%)

0.185 (0.136, 0.254)

 < 0.00001

 Glomerulonephritis

178 (18.503%)

0.295 (0.208, 0.419)

 < 0.00001

 Other

155 (16.112%)

0.174 (0.110, 0.277)

 < 0.00001

 BMI(kg/m2)

23.756 ± 4.072

1.027 (0.995, 1.059)

0.09929

 SBP(mmHg)

139.388 ± 21.853

1.017 (1.012, 1.022)

 < 0.00001

 HB(g/dL)

12.055 ± 2.213

0.691 (0.651, 0.733)

 < 0.00001

 Scr(mg/dL)

2.144 ± 1.469

1.449 (1.396, 1.505)

 < 0.00001

 eGFR (ml/min per 1.73 m2)

33.037 ± 18.007

0.917 (0.906, 0.929)

 < 0.00001

 ALB(g/dL)

3.874 ± 0.605

0.349 (0.299, 0.407)

 < 0.00001

Urinary occult blood

 No

652 (67.775%)

1.0

 

 Yes

310 (32.225%)

1.658 (1.290, 2.130)

0.00008

 UPCR(g/gCr)

2.037 ± 3.189

1.208 (1.183, 1.234)

 < 0.00001

Hypertension

 No

96 (9.979%)

1.0

 

 Yes

866 (90.021%)

4.070 (1.920, 8.627)

0.00025

History of CVD

 No

704 (73.181%)

1.0

 

 Yes

258 (26.819%)

1.262 (0.962, 1.655)

0.09277

Diabetes

 No

598 (62.162%)

1.0

 

 Yes

364 (37.838%)

2.699 (2.101, 3.466)

 < 0.00001

Use of RAAS inhibitor

 No

336 (34.927%)

1.0

 

 Yes

626 (65.073%)

1.727 (1.293, 2.308)

0.00022

Use of calcium channel blocker

 No

503 (52.287%)

1.0

 

 Yes

459 (47.713%)

1.724 (1.338, 2.221)

0.00002

Use of diuretics

 No

650 (67.568%)

1.0

 

 Yes

312 (32.432%)

2.197 (1.715, 2.815)

 < 0.00001